Multiple Sclerosis Trial, Not Yet Recruiting NCT06982742 Sponsor: Meryem Kocaslan Toran Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT06982742
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are 18 years of age or older
  • People who have been formally diagnosed with Multiple Sclerosis (MS) based on a specific set of diagnostic standards called the McDonald 2017 criteria
  • People who own a smartphone that runs on the Android operating system
  • People whose level of physical disability, as assessed by a doctor using a standard scale (EDSS), is scored at 5 or below
  • People who are able to communicate in Turkish
  • People who are able to read and write
  • People who do not have any neurological symptoms (such as tremors) that would make using a smartphone difficult
  • People who score 19 or higher on a pain questionnaire called the Pain Detect Pain Questionnaire
  • People who score 4 or higher on a questionnaire called the Neuropathic Pain Questionnaire
  • People who score below 17 on a depression questionnaire called the Beck Depression Scale

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had surgery on their muscles, bones, or joints within the past six months
  • People who have a known neurological condition such as epilepsy or dementia
  • People who have vision or hearing problems that could affect their ability to complete the study tests
  • People whose chronic pain is not related to nerve-based (neuropathic) causes, such as pain from cancer, carpal tunnel syndrome, or post-shingles pain
  • People who have blood vessel complications related to diabetes or other causes affecting the limbs
  • People who are currently taking part in any supervised, home-based, or group exercise program as part of physical therapy
  • People who are currently receiving psychological therapies such as cognitive and/or behavioural therapy or biofeedback
  • People who are currently practising mind-body activities such as yoga or tai chi
  • People who are currently receiving acupuncture treatment
  • People who are currently receiving invasive treatments such as injections, nerve blocks, spinal cord stimulators, or medications given through a drip or injection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00905066000080

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Meryem Kocaslan Toran
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
1 October 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Reduction in Neuropathic Pain Intensity Measured by Visual Analog Scale (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov